Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2025

Mar 13, 2025

29995_dirs_2025-03-13_52f31c43-4875-4516-99e1-425bd4d2e2c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2025-03-11

Reporting Person: Kennard William E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-11 Common Stock A 291 $78.45 Acquired 42199 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10 Indirect

Footnotes

F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

F2: Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.